DanielWeiLinMD

PubMed

• The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance.
  Jonathan L Wright, Jeannette M Schenk, Roman Gulati, Sarah J Beatty, Matthew VanDoren, Daniel W Lin, Michael P Porter, Colm Morrissey, Atreya Dash, John L Gore, Ruth E...> ;Cancer. 2024 Feb 14
• High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker.
  Liu, S., Hawley, S., Kunder, C., Hsu, E., Shen, M., Westphalen, L., Auman, H., Newcomb, L., Lin, D., Nelson, P., Feng, Z., Tretiakova, M., True, L., Vakar-Lopez, F., C...> ;Scientific Reports. 2024 Jan 4
• Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers.
  Ailin Zhang, Nathan A Lau, Alicia Wong, Lisha G Brown, Ilsa M Coleman, Navonil De Sarkar, Dapei Li, Diana C DeLucia, Mark P Labrecque, Holly M Nguyen, Jennifer L Conne...> ;Cancer Research Communications. 2023 Nov 20
• Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer.
  Mark P Labrecque, Lisha G Brown, Ilsa M Coleman, Holly M Nguyen, Susan Dalrymple, W Nathaniel Brennen, John T Isaacs, Dapei Li, Bryce Lakely, Diana C DeLucia, John K L...> ;The Prostate. 2024 Jan 1
• Putting patients first to redefine prostate cancer classifications.
  Yaw A Nyame, John L Gore, Daniel W Lin> ;Journal of the National Cancer Institute. 2023 Nov 8
• 1 citations
  Androgen-regulated stromal complement component 7 (C7) suppresses prostate cancer growth.
  Zhicheng Zhou, Deyong Jia, Ohjoon Kwon, Shan Li, Huiyun Sun, Martine P Roudier, Daniel W Lin, Lawrence True, Colm Morrissey, Chad J Creighton, John K Lee, Li Xin> ;Oncogene. 2023 Aug 1
• Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.
  Palak Patel, Stephanie Harmon, Rachael Iseman, Olga Ludkowski, Heidi Auman, Sarah Hawley, Lisa F Newcomb, Daniel W Lin, Peter S Nelson, Ziding Feng, Hilary D Boyer, Ma...> ;Modern Pathology. 2023 Oct 1
• 11 citations
  Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy.
  John T Wei, Daniel Barocas, Sigrid Carlsson, Fergus Coakley, Scott Eggener, Ruth Etzioni, Samson W Fine, Misop Han, Sennett K Kim, Erin Kirkby, Badrinath R Konety, Mar...> ;The Journal of Urology. 2023 Jul 1
• 21 citations
  Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening.
  John T Wei, Daniel Barocas, Sigrid Carlsson, Fergus Coakley, Scott Eggener, Ruth Etzioni, Samson W Fine, Misop Han, Sennett K Kim, Erin Kirkby, Badrinath R Konety, Mar...> ;The Journal of Urology. 2023 Jul 1
• 1 citations
  Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy.
  Rishi R Sekar, Leonidas N Diamantopoulos, Dimitra R Bakaloudi, Ali R Khaki, Petros Grivas, Brian R Winters, Funda Vakar-Lopez, Maria S Tretiakova, Sarah P Psutka, Sara...> ;Clinical Genitourinary Cancer. 2023 Aug 1
• Point-Counterpoint: Active Surveillance Should Still Be Preferred Management for All (or Nearly All) Men With Low-risk Prostate Cancer.
  Daniel W Lin> ;The Journal of Urology. 2023 Mar 1
• 1 citations
  Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation.
  Michael S Leapman, Rong Wang, Stacy Loeb, Tyler M Seibert, Franklin D Gaylis, Ben Lowentritt, Gordon A Brown, Ronald Chen, Daniel Lin, John Witte, Matthew R Cooperberg...> ;The Journal of Urology. 2023 Apr 1
• Reply by Authors.
  Michael T Schweizer, Lawrence True, Roman Gulati, Yibai Zhao, William Ellis, George Schade, Bruce Montgomery, Sonia Goyal, Katie Nega, Alexander K Hakansson, Yang Liu,...> ;The Journal of Urology. 2023 Feb 1
• 1 citations
  Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.
  Michael T Schweizer, Lawrence True, Roman Gulati, Yibai Zhao, William Ellis, George Schade, Bruce Montgomery, Sonia Goyal, Katie Nega, Alexander K Hakansson, Yang Liu,...> ;The Journal of Urology. 2023 Feb 1
• 8 citations
  A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive ne...
  Evan E Gross, Mingjia Li, Ming Yin, Delaney Orcutt, Duncan Hussey, Elliot Trott, Sarah K Holt, Erin R Dwyer, Joel Kramer, Kaylee Oliva, John L Gore, George R Schade, D...> ;Urologic Oncology. 2023 Jan 1
• 3 citations
  A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer.
  Dimitrios Makrakis, Jonathan L Wright, Martine P Roudier, Jose Garcia, Funda Vakar-Lopez, Michael P Porter, Yan Wang, Atreya Dash, Daniel Lin, George Schade, Brian Win...> ;Clinical Genitourinary Cancer. 2023 Apr 1
• 7 citations
  Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunity.
  Deyong Jia, Zhicheng Zhou, Oh-Joon Kwon, Li Zhang, Xing Wei, Yiqun Zhang, Mingyang Yi, Martine P Roudier, Mary C Regier, Ruth Dumpit, Peter S Nelson, Mark Headley, Law...> ;Nature Communications. 2022 Nov 11
• 2 citations
  Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.
  Lauren Brady, Lisa F Newcomb, Kehao Zhu, Yingye Zheng, Hilary Boyer, Navonil De Sarkar, Jesse K McKenney, James D Brooks, Peter R Carroll, Atreya Dash, William J Ellis...> ;Cancer Medicine. 2022 Nov 1
• 2 citations
  Changes in skeletal muscle and adipose tissue during cytotoxic chemotherapy for testicular germ cell carcinoma and associations with adverse events.
  Anthea Phuong, J Peter Marquardt, Ryan O'Malley, Sarah K Holt, Grace Laidlaw, Zachary Eagle, Steven Ngo, Delaney Orcutt, George R Schade, Daniel W Lin, Michael T Schwe...> ;Urologic Oncology. 2022 Oct 1
• 8 citations
  Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenoc...
  Emily Chan, Jesse K McKenney, Sarah Hawley, Dillon Corrigan, Heidi Auman, Lisa F Newcomb, Hilary D Boyer, Peter R Carroll, Matthew R Cooperberg, Eric Klein, Ladan Fazl...> ;Modern Pathology. 2022 Aug 1
• 2 citations
  Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.
  Christopher P Filson, Kehao Zhu, Yijian Huang, Yingye Zheng, Lisa F Newcomb, Sierra Williams, James D Brooks, Peter R Carroll, Atreya Dash, William J Ellis, Martin E G...> ;The Journal of Urology. 2022 Nov 1
• 50 citations
  Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up.
  James A Eastham, Gregory B Auffenberg, Daniel A Barocas, Roger Chou, Tony Crispino, John W Davis, Scott Eggener, Eric M Horwitz, Christopher J Kane, Erin Kirkby, Danie...> ;The Journal of Urology. 2022 Jul 1
• 91 citations
  Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management.
  James A Eastham, Gregory B Auffenberg, Daniel A Barocas, Roger Chou, Tony Crispino, John W Davis, Scott Eggener, Eric M Horwitz, Christopher J Kane, Erin Kirkby, Danie...> ;The Journal of Urology. 2022 Jul 1
• 21 citations
  Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions.
  James A Eastham, Gregory B Auffenberg, Daniel A Barocas, Roger Chou, Tony Crispino, John W Davis, Scott Eggener, Eric M Horwitz, Christopher J Kane, Erin Kirkby, Danie...> ;The Journal of Urology. 2022 Jul 1
• 13 citations
  Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials ...
  Heiko Schöder, Thomas A Hope, Michael Knopp, William K Kelly, Jeff M Michalski, Seth P Lerner, Abdul Tawab-Amiri, Bhupinder S Mann, Daniel W Lin, Evan Y Yu, Ronald C C...> ;Journal of Clinical Oncology. 2022 May 1
• Join now to see all

Journal Articles

• Testicular Cancer Guidelines.  
  Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, Le..., J Natl Compr Canc Netw 10:502-35
• Treatment of Metastatic Prostate Cancer – How Urologists should Sequence Available Agents.  
  Mostaghel EA and Lin DW, AUA Update Series
• Is Pre-diagnosis PSA Velocity Predictive of the Risk of Death from Prostate Cancer Following Radical Prostatectomy?  
  Lin DW and Lange PH, Nature Clinical Practice Urology 1: 66
• Re: Prostate-specific Antigen Velocity in Men with Total Prostate-Specific Antigen Levels Less Than 4ng/ml.  
  Lin DW, Journal of Urology 178: 2352-3
• Re: Prostate-specific antigen velocity and prostate cancer gleason grade and stage.  
  Lin DW, Urologic Oncology 25: 529
• Re: Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome.  
  Lin DW, Urologic Oncology 25: 527-8
• Re: EPCA-2: A highly specific serum marker for prostate cancer.  
  Lin DW, Urologic Oncology 25: 528
• Re:Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.  
  Lin DW, Urologic Oncology 25: 528-9
• Re: Marked Gene Transcript Level Alterations Occur Early During Radical Prostatectomy.  
  Lin DW, Eur Urology 53: 345-6
• Re: Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance.  
  Lin DW, Urologic Oncology 26: 680-1
• Re: Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer.  
  Lin DW, Urologic Oncology 26: 681-2
• Re: Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after prostatectomy.  
  Lin DW, Urologic Oncology 26: 682-3
• Re: Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.  
  Lin DW, Journal of Urology
• Re: Adjuvant radiotherapy for patients with locally advanced prostate cancer – a new standard?  
  Lin DW, Urologic Oncology
• Re: Primary Retroperitoneal Lymph Node Dissection in Patients With Clinical Stage IS Testis Cancer.  
  Lin DW, Journal of Urology 182:2720
• Prostate cancer risk stratification by genotype and PSA.  
  Wright JL and Lin DW, Nature Reviews Urology 6:641-2
• Re: Mortality results from a randomized prostate-cancer screening trial: Andriole GL, Crawford ED, Grubb RL III, et al.  
  Lin DW, Urologic Oncology 27: 688-9
• Re: Improved sensitivity for detecting micrometastases in pelvic lymph nodes by real-time reverse transcriptase polymerase chain reaction (RT-PCR) compared with conven...  
  Lin DW, Urologic Oncology 27: 689-90
• Re: Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer: Attard G, Reid AH, A'Hern R, et al.  
  Lin DW, Urologic Oncology 27: 690-1
• Re: Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?: Tareen B, Godoy G, Sankin A, et al.  
  Lin DW, Urologic Oncology 27: 691
• Re: Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer: Morris MJ, Huang D, Kelly WK, et al.  
  Lin DW, Urologic Oncology 27: 692
• Value of Urethral Wash after Radical Cystectomy.  
  Lin DW, Herr HW, Dalbagni G, Journal of Urology 165 (5 suppl): 715A
• Phenotypic Heterogeneity in Disseminated Prostate Cancer Tumor Cells: Implications in Epithelial to Mesenchymal Transition.  
  Koreckij TD, Morgan TM, Lange PH, Coleman I, Coleman R, Ellis WJ, Lin DW, Montgomery B, Lakely B, Morrissey C, and Vessella RL, Journal of Urology 181 (4 suppl): 2086A
• The Effect of Sequential Compression Devices on Intraoperative Blood Loss During Radical Prostatectomy.  
  Koch MO, Brandell RA, Lin D, Smith JA, Journal of Urology 152: 1178-9
• Transition Zone PSA Density: Lack of Utility in Prediction of Prostatic Carcinoma.  
  Lin DW, Gold MH, Ransom S, Ellis WJ, Brawer MK, Journal of Urology 160: 77-82
• Join now to see all

Books/Book Chapters

• Prostate Cancer: Principles and Practice. 
  Chapter: Tumor Markers in Prostate Cancer 
  Page 305 - 312Lin DW, Vessella RL, and Lange PHEditors: P Carroll and A D’Amico.W.B. Saunders Co
• Management of Prostate Cancer: Advances and Controversies. 
  Chapter: Anatomical Radical Prostatectomy in the Management of Localized Prostate Cancer 
  Page 55 - 60Lin DW, Eastham JA, and Scardino PTEditors: KB Cummings.Marcel Dekker, Inc
• Mechanisms of Metastasis. 
  Chapter: Detection, Isolation, and Study of Disseminated Prostate Cancer Cells in the Peripheral Blood and Bone Marrow 
  Lin DW, Pfitzenmaier J, Ellis WJ, Lange PH, and Vessella RLEditors: C Rinker-Schaeffer.Humana Press, Inc
• Prostate Cancer: Principles and Practice. 
  Chapter: PSA: Practical Applications and Future Prospects 
  Lin DW and Brawer MKEditors: R Kirby, A Partin, M Feneley, JK Parsons.Martin Dunitz Ltd
• Intermittent Androgen Deprivation: Clinical Experience and Practical Applications. 
  Page 167 - 169Wright JL, Higano CS, and Lin DWEditors: J Smith.Saunders Inc
• Role of Post-Chemotherapy Surgery in Germ Cell Tumors. 
  Page 199 - 217Sim HG, Lange PH, and Lin DWEditors: J Sheinfeld.Saunders Inc
• Complications of Urologic Surgery: Prevention and Management. 
  Chapter: Toxicities of Chemotherapy for Genitourinary Malignancies 
  Page 117 - 124Montgomery RB and Lin DWEditors: SS Taneja.Elsevier Inc
• Comprehensive Textbook of Genitourinary Oncology. 
  Chapter: Role of Post-Chemotherapy Surgery in Germ Cell Tumors 
  Sim HG and Lin DWEditors: N Vogelzang, P Scardino.
• Practical Cases in Urology. 
  Chapter: Current Management of Testis Cancer 
  Lin DW and Lange PHEditors: AJ Wein.American Urological Association, Inc
• Prostatic Diseases. 
  Chapter: Epidemiology and Natural History of Prostate Cancer 
  Page 345 - 356Lin DW and Lange PHEditors: H Lepor.W.B.Saunders Co
• Join now to see all

Abstracts/Posters

• Efficacy of Acucise Incision on Uretero-Enteral Strictures.
  Lin DW, Bush WH, Mayo ME, Northwest Urologic Association, Portland, OR
• Transurethral Needle Ablation of the Prostate for Treatment of Benign Prostatic Hyperplasia: the University of Washington Experience.
  Lin DW, Ellis WJ, Northwest Urological Society, Seattle, WA
• Primary Penile Lymphoma Treated With Surgical Excision.
  Lin DW, Krieger JN, Northwest Urological Society, Seattle, WA
• Salvage Cystoprostatectomy for Treatment of Recurrent Prostate Cancer After Radiation Treatment.
  Lin DW, Ellis WJ, Lange PH, American Urological Association
• Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) in Bone Marrow Aspirates Following Radical Prostatectomy with Extended Follow-up.
  Lin DW, Ellis WJ, Arfman EW, Sohn A, Corey E, Lange PH, Vessella RL, American Urological Association
• Transurethral Needle Ablation of the Prostate for Treatment of Benign Prostatic Hyperplasia: the University of Washington Experience.
  Lin DW, Ellis WJ, American Urological Association
• Serum Percent Free Prostate-Specific Antigen (f-PSA) in Metastatic Prostate Cancer.
  Lin DW, Noteboom JL, Ellis WJ, Blumenstein B, Lange PH, Vessella RL, Western Section American Urological Association
• Unexplained Elevated Prostate-Specific Antigen: Diagnostic Approach and Unique Clinical Considerations.
  Lin DW, Ellis WJ, Lange PH, Vessella RL, Northwest Urological Society
• Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) for Detection of Prostate Cancer Micrometastases in Pelvic Lymph Nodes (LN), Bone Marrow (BM), and Peripheral ...
  Lin DW, Ellis WJ, True LD, Lange PH, Vessella RL, Northwest Urological Society
• Serum Human Glandular Kallikrein (hK2) in Metastatic Prostate Cancer.
  Lin DW, Ellis WJ, Lange PH, Vessella RL, Finlay JA, Rittenhouse HG, and Day J, American Urological Association
• The LuCaP Prostate Cancer Xenografts: Establishment and Characterization.
  Lin DW, Ellis WJ, Buhler K, Quinn J, Vessella RL, Lange PH, Northwest Urological Society
• Cytoreductive Surgery for Metastatic Renal Cell Carcinoma: Operative Results and Impact on Adjuvant Therapy.
  Lin DW, Kuhr CS, Marsh CL, Ellis WJ, Thompson JA, Lange PH, Northwest Urological Society
• The LuCaP Prostate Cancer Xenografts: Establishment and Characterization.
  Lin DW, Ellis WJ, Buhler K, Quinn J, Vessella RL, Lange PH, Society for University Urologic Residents, Atlanta, GA
• Value of Urethral Wash after Radical Cystectomy.
  Lin DW, Herr HW, Dalbagni G, American Urological Association, Anaheim, CA
• Detection and Isolation of PSA Positive Epithelial Cells by Enrichment: Clinical Relevance, and Initial Characterization in Prostate Cancer Patients.
  Lin DW, Ellis WJ, Kinnunen M, Arfman EW, Klein JR, Lange PH, and Vessella RL, 12th SPORE Investigators Workshop, Washington, DC
• Diethylstilbestrol and docetaxel: a phase II study in patients with metastatic androgen independent prostate cancer.
  Montgomery B, Lin DW, Ryan C, Garzotto M, and Beer TM, Multidisciplinary Prostate Cancer Symposium, Orlando, FL
• Effect of Surgical Manipulation on Tissue Gene Expression: Impact on Endpoint Analyses.
  Lin DW, Coleman I, Hawley S, Dumpit R, Gifford D, Kezele P, and Nelson PS, 13th SPORE Investigators Workshop, Washington, DC
• Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis.
  Lin DW, Coleman I, Hawley S, Dumpit R, Gifford D, Kezele P, Hung H, Knudsen BS, Kristal AR, and Nelson PS, 6th Annual Society of Urologic Oncology Conference, 6th Annual Society of Urologic Oncology Conference
• Treatment patterns for young men with prostate cancer: a SEER database analysis.
  Montgomery RB, Porter M, and Lin DW, 2006 Multidisciplinary Prostate Symposium, San Francisco, CA
• Quality of Life in Young Men after Radical Prostatectomy: Results from the CAPSURE Registry.
  Wright JL, Lin DW, Cowan JE, DuChane J, Carroll PR, and Litwin MS, American Society of Clinical Oncology, 2006 Annual Meeting, Atlanta, GA
• Insulin and Glucagon Independent Effects of Calcitonin Gene Related Peptide in the Conscious Dog.
  Lin DW, Colburn C, Cherrington AD, Diabetes 41(Suppl 1): 51A
• Global gene expression changes in human prostate tissue in response to dietary intervention.
  Lin DW, Neuhouser ML, Schenk JM, Coleman IM, Hawley S, Gifford D, Hung H, Knudsen BS, Nelson PS, and Kristal AR, Western Section American Urological Association, Maui, HI
• The Effect of Toremifene on PSA Progression-Free Survival in Castrate Men with Detectable Baseline PSA Levels.
  Lin DW, Barnett G, Brawer MK, Smith M, Morton R, Steiner M, and Yu E, Northwest Urological Society Scientific Program, Bellevue, WA
• Toremifene Demonstrates Reduction in Fracture risk in Men Less Than 80 Years of Age on Androgen Deprivation Therapy.
  Lin DW, Marks LS, Morton RA, Steiner MS, and Brawer MK, Western Section American Urological Association, Hawaii
• Progression and treatment in a multi-institutional, prospective active surveillance study: Results from Canary Prostate Active Surveillance Study (PASS).
  Lin DW, Newcomb L, Ellis W, Gleave M, Thompson I, Brooks J, Nelson P, Sanda M, Lance R, Wei J, Feng Z, Carroll P, and Canary/EDRN Investigators, American Urological Association 2012 Annual Meeting, Atlanta, GA
• Join now to see all

Lectures

• PSA Best Practice Guidelines, Update on Cancer-Related AUA Guidelines: Preparation for Recertification. 
  Multiple locations, 2008
• The Role of Peri-Operative Chemotherapy in High-Risk Prostate Cancer: PUNCH and VA Surgical Trials. 
  3rd Annual John R. Murren Oncology Symposium, Las Vegas, NV
• Progress and Promise in Prostate Cancer. 
  Albany VA Grand Rounds, Albany, NY
• Beyond PSA: Utility of Novel Prostate Cancer Markers in Advanced Disease. 
  Moffitt Cancer Center Advanced Prostate Cancer Collaboration, Tampa, FL
• The Effects of Sulforaphane on Normal Human Prostate Cells: Mechanisms of Cancer Prevention and Rationale for Clinical Trial. 
  Pacific NW Prostate Cancer SPORE External Advisory Board Symposium, Seattle, WA
• Prostate Cancer Screening and Evaluation and Treatment of Newly Diagnosed Prostate Cancer. 
  Puget Sound Health Care System Prostate Cancer Awareness Month Symposium, Seattle, WA
• Prostate Cancer Screening and Rationale For/Against Early Detection of Localized Prostate Cancer. 
  Annual Advances in Family Practice and Primary Care, Seattle, WA
• Risk Stratification, Mechanisms of Recurrence, and Adjuvant Treatment Strategies for High-Risk Post-Prostatectomy Prostate Cancer. 
  Scott Department of Urology Grand Rounds, Baylor University School of Medicine, Houston, TX
• Adjuvant Treatment Strategies for High-Risk Post-Prostatectomy Prostate Cancer: Emerging Data and New Directions. 
  Multiple locations, 2007
• Non-Muscle Invasive Bladder Cancer: AUA Management Guidelines. 
  American Urological Association 2008 Annual Meeting CME Course Faculty, Orlando, FL
• Beyond PSA: Utility of Novel Tumor Markers in the Setting of Elevated PSA. 
  American Urological Association 2008 Annual Meeting, Orlando, FL
• Management of High Risk Prostate Cancer. 
  Urology Research Forum, Charles University, Prague, Czechoslovakia
• Diagnosis and Management of Clinically Localized Prostate Cancer 2007. 
  Seattle Cancer Care Alliance Outreach Symposium, Great Falls, MT
• Prostate Carcinogenesis. 
  Men’s Health Update CME Course, Seattle, WA
• Prostate Anatomy and Evaluation of Lower Urinary Tract Symptoms. 
  Men’s Health Update CME Course, Seattle, WA
• Clinical Scenarios and Treatment Strategies for Advanced Prostate Cancer in Younger Men. 
  Multiple locations, 2006
• Screening and Diagnosis of Prostate Cancer. 
  Providence Saint Joseph Medical Center Grand Rounds, Burbank, CA
• Everything You Want To Know About Prostate Cancer in 2007. 
  American Association of Pediatric Ophthalmology and Strabismus Annual Meeting, Seattle, WA
• Progress and Promise in Prostate Cancer Research. 
  VA R&D Research Colloquium, Seattle, WA
• Adjuvant Chemohormonal Therapy in High Risk Prostate Cancer: a Point-Counterpoint Debate. 
  Northwest Urological Society Annual Meeting, Spokane, WA
• Prostate Cancer Update 2006. 
  Evergreen Hospital Grand Rounds, Kirkland, WA
• Prostate Cancer Screening. 
  34th Annual Advances in Family Practice and Primary Care, Seattle, WA
• High-Risk Prostate Cancer: Treatment Controversies and the Multidisciplinary Approach. 
  Fred Hutchinson Cancer Research Center Clinical Oncology Grand Rounds, Seattle, WA
• Prostate Cancer: Diagnosis and Treatment. 
  Skagit Valley Cancer Center Symposium, Mount Vernon, WA
• Prostate Cancer Prevention: Myth or Reality? 
  Male Genitourinary Health Update, Spokane County Medical Society, Spokane, WA
• Join now to see all